Skip to main navigation CytomX About Probody Therapeutics Pipeline Partners Investors & News Culture & Careers Xciting things are happening here Annual Reports February 24, 2021 2020 Annual Report February 27, 2020 2019 Annual Report February 27, 2019 2018 Annual Report March 7, 2018 2017 Annual Report March 2, 2017 2016 Annual Report March 8, 2016 2015 Annual Report Corporate Profile Press Releases Events and Presentations Scientific Publications Corporate Governance Stock Information Financials & Filings Annual Reports Quarterly Results SEC Filings Analyst Coverage Investor Resources INVESTOR TOOLS Print Page Email Page RSS Feeds Email Alerts Contact IR Contact Us 151 Oyster Point Blvd, Suite 400 South San Francisco, CA 94080-1913 IR@CytomX.com Share Linkedin Twitter © 2021 CYTOMX INC | CYTOMX, our corporate logo, IHZ, and PROBODY are trademarks of CytomX Therapeutics, Inc. All other brands and trademarks referenced herein are the property of their respective owners. About Overview Vision & Mission Our Values Executive Team Board of Directors Contact Us Probody Therapeutics Our Probody Approach How Probody Therapeutics Work A Versatile Platform Scientific Publications & Presentations Pipeline Advancing a Pipeline Lead Candidates Clinical Trials Access for HCPs/Patients Partners Opportunities Current Partners Investors & News Corporate Profile Press Releases Events & Presentations Scientific Publications Corporate Governance Stock Information Financials & Filings Annual Meeting Analyst Coverage Investor Resources Culture & Careers Overview Xtraordinary Culture Current Openings Total Rewards Program Corporate Amenities Home Terms of Use Privacy Policy